Hydralazine Hydrochloride 25mg Tablets from Japan
These are oral tablets containing 25mg of hydralazine hydrochloride, a vasodilator used to treat hypertension and heart failure. Classified under HTS 3004.90.92.20 as a cardiovascular medicament put up in measured doses for retail sale, consisting of unmixed active ingredient in tablet form.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Obtain FDA approval and NDC registration prior to import; ensure product meets US pharmacopeia standards for hydralazine content
• Include certificate of analysis verifying purity and stability; label with lot number, expiry date, and storage conditions
• Avoid common pitfalls like improper temperature control during shipping, which can degrade the active ingredient